
Mortality after deferral of treatment or no treatment for choroidal melanoma
Author(s) -
Bradley R. Straatsma,
Marie DienerWest,
Robert Caldwell,
Robert E. Engstrom
Publication year - 2018
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_1499_18
Subject(s) - medicine , melanoma , ocular melanoma , clinical trial , confidence interval , cohort study , surgery , cancer research
To report mortality of patients who were eligible for enrollment in the Collaborative Ocular Melanoma Study (COMS) clinical trials of medium-sized choroidal melanoma or large-sized choroidal melanoma but chose to defer treatment or receive no melanoma treatment.